𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Deletion of 8.5 Mb, including theFMR1 gene, in a male with the fragile X syndrome phenotype and overgrowth

✍ Scribed by Parvari, R.; Mumm, S.; Galil, A.; Manor, E.; Bar-David, Y.; Carmi, R.


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
29 KB
Volume
83
Category
Article
ISSN
0148-7299
DOI
10.1002/(sici)1096-8628(19990402)83:4<302::aid-ajmg13>3.0.co;2-p

No coin nor oath required. For personal study only.

✦ Synopsis


A four-year-old boy with severe psychomotor retardation, facial appearance consistent with the fragile X syndrome, hypotonia, and overgrowth was found to have a deletion including the fragile X gene (FMR1). The breakpoints of the deletion were established between CDR1 and sWXD2905 (approximately 200 kb apart) at Xq27.1 (centromeric) and between DXS8318 (612-1078L) and DXS7847 (576-291L) (approximately 250 kb apart) at Xq28, about 500 kb telomeric to the FMR1 gene. The total length of the deletion is approximately 8.5 Mb. The propositus's mother, who was found to be a carrier of the deletion, showed very mild mental impairment. Except for mental retardation, which is a common finding in all cases reported with similar deletions of chromosome Xq, this patient had generalized overgrowth, exceeding the 97th centile for height and weight. Obesity and increased growth parameters have been reported in other patients with deletions either overlapping or within a distance of 0.5 Mb from the deletion in the present patient. Thus, it is suggested that a deletion of the 8-Mb fragment centromeric to the FMR1 gene might have an effect on growth. Am. J. Med. Genet. 83:302-307, 1999.


πŸ“œ SIMILAR VOLUMES


Genotype, molecular phenotype, and cogni
✍ Kaufmann, Walter E.; Abrams, Michael T.; Chen, Wilma; Reiss, Allan L. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 42 KB πŸ‘ 2 views

The study of the neurobehavioral consequences of mutations of FMR1, the gene responsible for fragile X syndrome (FraX), has been based largely on correlations between mutation patterns and cognitive profile. Following the characterization of FMRP, the FMR1 gene product, preliminary correlations betw

Tissue heterogeneity of theFMR1 mutation
✍ Taylor, Annette K.; Tassone, Flora; Dyer, Pamela N.; Hersch, Steven M.; Harris, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 33 KB πŸ‘ 2 views

Few studies have been conducted comparing the FMR1 mutation in multiple tissues of individuals affected with fragile X syndrome. We report a postmortem study of the FMR1 mutation in multiple tissues from a high-functioning male with fragile X syndrome. This man was not mentally retarded and had only

FMR1 gene expression in olfactory neurob
✍ Abrams, Michael T.; Kaufmann, Walter E.; Rousseau, FranοΏ½ois; Oostra, Ben A.; Wol πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 17 KB πŸ‘ 1 views

The fragile X mental retardation 1 gene (FMR1) mutation is strongly correlated with specific and marked neurobehavioral and neuroanatomical abnormalities. The protein product, FMRP, is highly expressed in neurons of the normal mammalian brain, and absent or in low levels in leukocytes from individua

Do NF1 gene deletions result in a charac
✍ Tonsgard, James H.; Yelavarthi, Krishna K.; Cushner, Shana; Priscilla Short, M.; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 1 views

Neurofibromatosis-1 (NF1) is an autosomal dominant disorder with marked variability of expression. Analysis of the NF1 gene (NF1) has detected a variety of mutations without any clear correlation with phenotype. However, deletions which remove all of NF1 have been reported in a small number of patie